Repligen Corporation to Present at William Blair Growth Conference
Repligen Corporation (NASDAQ:RGEN), a leading bioprocessing technology company, has announced its participation in the William Blair 45th Annual Growth Stock Conference. The event is scheduled for June 3-5 in Chicago. Olivier Loeillot, President and CEO, will deliver a company overview presentation on June 3rd at 1:20 p.m. CT. Investors can access the live webcast through Repligen's Investor Relations website, with a replay available for a limited time after the event.
Repligen Corporation (NASDAQ:RGEN), un'azienda leader nella tecnologia di bioprocessing, ha annunciato la sua partecipazione al William Blair 45th Annual Growth Stock Conference. L'evento si terrà dal 3 al 5 giugno a Chicago. Olivier Loeillot, Presidente e CEO, presenterà una panoramica dell'azienda il 3 giugno alle 13:20 CT. Gli investitori potranno seguire la diretta streaming tramite il sito web delle Relazioni con gli Investitori di Repligen, con la possibilità di rivedere la registrazione per un periodo limitato dopo l'evento.
Repligen Corporation (NASDAQ:RGEN), una empresa líder en tecnología de bioprocesos, ha anunciado su participación en la William Blair 45th Annual Growth Stock Conference. El evento se llevará a cabo del 3 al 5 de junio en Chicago. Olivier Loeillot, Presidente y CEO, ofrecerá una presentación general de la empresa el 3 de junio a la 1:20 p.m. CT. Los inversores podrán acceder a la transmisión en vivo a través del sitio web de Relaciones con Inversores de Repligen, con una repetición disponible por tiempo limitado después del evento.
Repligen Corporation (NASDAQ:RGEN)은 선도적인 바이오프로세싱 기술 회사로서 William Blair 45th Annual Growth Stock Conference에 참가할 것이라고 발표했습니다. 행사는 6월 3일부터 5일까지 시카고에서 열립니다. Olivier Loeillot 사장 겸 CEO가 6월 3일 오후 1시 20분(중부 표준시)에 회사 개요 프레젠테이션을 진행할 예정입니다. 투자자들은 Repligen의 투자자 관계 웹사이트를 통해 생중계에 접속할 수 있으며, 행사 후 일정 기간 동안 다시보기 서비스도 제공됩니다.
Repligen Corporation (NASDAQ:RGEN), une entreprise leader dans la technologie des bioprocédés, a annoncé sa participation à la William Blair 45th Annual Growth Stock Conference. L'événement est prévu du 3 au 5 juin à Chicago. Olivier Loeillot, Président et CEO, présentera un aperçu de l'entreprise le 3 juin à 13h20 CT. Les investisseurs pourront accéder à la diffusion en direct via le site des Relations Investisseurs de Repligen, avec un replay disponible pour une durée limitée après l'événement.
Repligen Corporation (NASDAQ:RGEN), ein führendes Unternehmen im Bereich Bioprozess-Technologie, hat seine Teilnahme an der William Blair 45th Annual Growth Stock Conference angekündigt. Die Veranstaltung findet vom 3. bis 5. Juni in Chicago statt. Olivier Loeillot, Präsident und CEO, wird am 3. Juni um 13:20 Uhr CT eine Unternehmensübersicht präsentieren. Investoren können den Live-Webcast über die Investor-Relations-Website von Repligen verfolgen, mit einer zeitlich begrenzten Wiederholung nach der Veranstaltung.
- None.
- None.
WALTHAM, Mass., May 22, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the William Blair 45th Annual Growth Stock Conference being held June 3 – 5 in Chicago. Olivier Loeillot, President and Chief Executive Officer is scheduled to present a company overview on June 3rd at 1:20 p.m. CT.
A live webcast of the conference presentation will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the event.
About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the company see our website at www.repligen.com, and follow us on LinkedIn.
Repligen Contact:
Jacob Johnson
VP, Investor Relations
(781) 419-0204
investors@repligen.com
FAQ
When is Repligen (RGEN) presenting at the William Blair Growth Conference 2025?
Who will present for Repligen (RGEN) at the William Blair Conference?
How can investors watch Repligen's (RGEN) presentation at the William Blair Conference?
What is the duration of the William Blair Growth Conference 2025?
